✦ LIBER ✦

Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study

✍ Scribed by Jean-Pierre Zarski; Nathalie Sturm; Hervé Desmorat; Pascal Melin; Jean-Jacques Raabe; Corinne Bonny; Philippe Sogni; Alexandrina Pinta; Stéphanie Rouanet; Gérard Babany; Alice Cheveau; Michèle Chevallier

Book ID: 111239311
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 422 KB
Volume: 30
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2010.02265.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiviral therapy and fibrosis progressi

Antiviral therapy and fibrosis progression in patients with mild–moderate hepatitis C recurrence after liver transplantation. A randomized controlled study

✍ Luca S. Belli; Riccardo Volpes; Ivo Graziadei; Stefano Fagiuoli; Peter Starkel; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Transient elastrography a new non invasi

Transient elastrography a new non invasive method for assessment of liver fibrosis: Results in patients with HCV chronic hepatitis

✍ R. Palau; F. Mal; C. Christidis; M. Ziol; L. Sandrin; C. Fournier; B. Fourquet; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Von Willebrand Factor as a new marker fo

Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

✍ Maieron, A.; Salzl, P.; Peck-Radosavljevic, M.; Trauner, M.; Hametner, S.; Schöf 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

Factors influencing the progression of f

Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: A retrospective analysis of 939 liver biopsies in a single center

✍ Thomas Walter; Jérôme Dumortier; Olivier Guillaud; Valérie Hervieu; Jean-Yves Sc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

Recurrent hepatitis C after liver transplantation (LT) is a major problem, since up to 30% of patients develop cirrhosis only 5 years after LT in the absence of antiviral therapy. The aim of this study was to examine the rate of progression of fibrosis and its associated risk factors in patients sub

555 Long-term progression of fibrosis in

555 Long-term progression of fibrosis in patients with chronic hepatitis C (CHC) non-responders to interferon therapy (IFN). A longitudinal study of repeat liver biopsies

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Non-invasive prediction of the degree of

Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent. A pilot study

✍ J Searle; R Mendelson; M Zelesco; J Sanford; W Cheng; C McKinstry; D Ramsay 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 583 KB